Fulgent Genetics is a American stock, trading under the symbol FLGT-Q on the NASDAQ (FLGT). It is usually referred to as NASDAQ:FLGT or FLGT-Q
In the last year, 1 stock analyst published opinions about FLGT-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Fulgent Genetics.
Fulgent Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Fulgent Genetics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Fulgent Genetics published on Stockchase.
On 2024-05-17, Fulgent Genetics (FLGT-Q) stock closed at a price of $22.12.
We have some comments posted on FLGT. While it is not without potential, it is likely going to get worse before it bets better, growth-wise. The most recent quarterly earnings were fine as revenue continued to decline, but beat estimates, along with EPS. There are positives as the pharma side of the business is making progress with over 30 issued or active patents and a promising lead drug candidate. The balance sheet does continue to be strong. We are OK selling.
Unlock Premium - Try 5i Free